- SPACs
- ALPHA HEALTHCARE ACQUISITION CORP III
ALPHA HEALTHCARE ACQUISITION CORP III
Completed 2023-07-14- CIK 1842939
- ALPA
- Now CTCX
- IPO 2021-07-27
- $29.4M trust
- 335 filings
Successfully merged with Axolotl Biologix, Inc. • Now trading as CTCX
- IPO Size
- $150M
- raised at the IPO
- Trust
- $29.4M
- as of 2023-07-11
- Current Status
- Completed
- from its latest filing
- IPO Year
- 2021
- year it listed
Filings, by quarter
335 filings over 23 quarters; violet bars carry a milestone
- 21 Q1: 11 filings
- 21 Q2: 1 filing
- 21 Q3: 25 filings
- 21 Q4: 2 filings
- 22 Q1: 5 filings
- 22 Q2: 3 filings
- 22 Q3: 4 filings
- 22 Q4: 2 filings
- 23 Q1: 17 filings
- 23 Q2: 24 filings
- 23 Q3: 37 filings
- 23 Q4: 29 filings
- 24 Q1: 19 filings
- 24 Q2: 23 filings
- 24 Q3: 34 filings
- 24 Q4: 19 filings
- 25 Q1: 26 filings
- 25 Q2: 21 filings
- 25 Q3: 8 filings
- 25 Q4: 8 filings
- 26 Q1: 4 filings
- 26 Q2: 6 filings
- 26 Q3: 7 filings
- S-1 filed 21 Q1
- IPO 21 Q3
- Definitive agreement 23 Q1
- Completed 23 Q3
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
- Registration2021-02-02 Filed S1
- IPO2021-07-27 IPO, search begins
- Definitive Agreement2023-01-04 Agreement for merger
- Completed2023-07-14 Merger Completed
About
Alpha Healthcare Acquisition Corp. III is a newly organized blank-check company seeking a business combination, with an intended focus on U.S. healthcare companies. It particularly seeks venture capital- and private equity-backed healthcare businesses.
Investment Focus
Healthcare
Geographic Focus
United States
Key Information
As the filings state it
- IPO Date
- 2021-07-27
- Total Redemptions
- $129M
- Jurisdiction of Incorporation
- Delaware
- SIC
- 6770
- Completion Date
- 2023-07-14
- Merger Target
- Axolotl Biologix, Inc.
- SPAC Ticker
- ALPA
- Merged Ticker
- CTCX
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
Led by Chairman and CEO Rajiv Shukla, with two decades of healthcare buyout, investment and operating experience and prior SPAC business-combination experience, and CFO Patrick A. Sturgeon, with nearly two decades of healthcare and other-sector M&A and equity-capital-markets experience.